AlphaCentric Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$341K Buy
2024
Q2
$163K Buy
2024
Q1
$105K Buy
2023
Q4
Sell
2023
Q3
$1.23M Buy
2023
Q2
$845K Hold
2023
Q1
$903K Hold
2022
Q4
$1.04M Hold
2022
Q3
$728K Buy